Back to Search
Start Over
COVID-19 pandemic, mechanical reperfusion and 30-day mortality in ST elevation myocardial infarction
- Source :
- Heart, 108(6), 458-466. BMJ Publishing Group, Heart, 108, 6, pp. 458-466, Heart, 108, 458-466, HEART, r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe, instname, De Luca, G, Algowhary, M, Uguz, B, Oliveira, D C, Ganyukov, V, Zimbakov, Z, Cercek, M, Jensen, L O, Loh, P H, Calmac, L, Roura-Ferrer, G, Quadros, A, Milewski, M, Scotto di Uccio, F, von Birgelen, C, Versaci, F, Ten Berg, J, Casella, G, Wong, A S L, Kala, P, Diez Gil, J L, Carrillo, X, Dirksen, M T, Becerra-Muñoz, V M, Kang-Yin Lee, M, Juzar, D A, de Moura Joaquim, R, Paladino, R, Milicic, D, Davlouros, P, Bakraceski, N, Zilio, F, Donazzan, L, Kraaijeveld, A O, Galasso, G, Lux, A, Marinucci, L, Guiducci, V, Menichelli, M, Scoccia, A, Yamac, A, Ugur Mert, K, Flores Rios, X, Kovarnik, T, Kidawa, M, Moreu, J, Flavien, V, Fabris, E, Lozano Martìnez-Luengas, I, Boccalatte, M & ISACS-STEMI COVID-19 2022, ' COVID-19 pandemic, mechanical reperfusion and 30-day mortality in ST elevation myocardial infarction ', Heart, vol. 108, no. 6, pp. 458-466 . https://doi.org/10.1136/heartjnl-2021-319750, Heart, r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol, r-INCLIVA. Repositorio Institucional de Producción Científica de INCLIVA
- Publication Year :
- 2022
- Publisher :
- BMJ PUBLISHING GROUP, 2022.
-
Abstract
- ObjectiveThe initial data of the International Study on Acute Coronary Syndromes - ST Elevation Myocardial Infarction COVID-19 showed in Europe a remarkable reduction in primary percutaneous coronary intervention procedures and higher in-hospital mortality during the initial phase of the pandemic as compared with the prepandemic period. The aim of the current study was to provide the final results of the registry, subsequently extended outside Europe with a larger inclusion period (up to June 2020) and longer follow-up (up to 30 days).MethodsThis is a retrospective multicentre registry in 109 high-volume primary percutaneous coronary intervention (PPCI) centres from Europe, Latin America, South-East Asia and North Africa, enrolling 16 674 patients with ST segment elevation myocardial infarction (STEMI) undergoing PPPCI in March/June 2019 and 2020. The main study outcomes were the incidence of PPCI, delayed treatment (ischaemia time >12 hours and door-to-balloon >30 min), in-hospital and 30-day mortality.ResultsIn 2020, during the pandemic, there was a significant reduction in PPCI as compared with 2019 (incidence rate ratio 0.843, 95% CI 0.825 to 0.861, p75 years) (p=0.015), and was not related to the peak of cases or deaths due to COVID-19. The heterogeneity among centres was high (pConclusionPercutaneous revascularisation for STEMI was significantly affected by the COVID-19 pandemic, with a 16% reduction in PPCI procedures, especially among older patients (about 20%), and longer delays to treatment, which may have contributed to the increased in-hospital and 30-day mortality during the pandemic.Trial registration numberNCT04412655.
- Subjects :
- Registrie
Male
ST Elevation Myocardial Infarction/diagnosis
Time Factors
Percutaneous
medicine.medical_treatment
Vascular damage Radboud Institute for Health Sciences [Radboudumc 16]
Coronary Artery Disease
Practice Patterns
030204 cardiovascular system & hematology
Rate ratio
Time-to-Treatment/trends
Cardiologists
0302 clinical medicine
Retrospective Studie
Heart Rate
Risk Factors
Pandemic
ST segment
Registries
Hospital Mortality
030212 general & internal medicine
Myocardial infarction
Practice Patterns, Physicians'
10. No inequality
Percutaneous Coronary Intervention/adverse effects
Hospital Mortality/trends
COVID-19
myocardial infarction
percutaneous coronary intervention
Incidence
Incidence (epidemiology)
Middle Aged
3. Good health
Treatment Outcome
Cardiology
Female
Cardiology and Cardiovascular Medicine
Cardiologists/trends
Human
Aged
Humans
Percutaneous Coronary Intervention
Retrospective Studies
Risk Assessment
ST Elevation Myocardial Infarction
Time-to-Treatment
medicine.medical_specialty
Time Factor
Coronavirus disease 2019 (COVID-19)
Cardiologist
03 medical and health sciences
Internal medicine
medicine
Acute Coronary Syndrome
Pandemics
Physicians'
SARS-CoV-2
business.industry
Risk Factor
COVID-19, myocardial infarction, percutaneous coronary intervention
Percutaneous coronary intervention
medicine.disease
Practice Patterns, Physicians'/trends
business
Subjects
Details
- Language :
- English
- ISSN :
- 13556037
- Database :
- OpenAIRE
- Journal :
- Heart, 108(6), 458-466. BMJ Publishing Group, Heart, 108, 6, pp. 458-466, Heart, 108, 458-466, HEART, r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe, instname, De Luca, G, Algowhary, M, Uguz, B, Oliveira, D C, Ganyukov, V, Zimbakov, Z, Cercek, M, Jensen, L O, Loh, P H, Calmac, L, Roura-Ferrer, G, Quadros, A, Milewski, M, Scotto di Uccio, F, von Birgelen, C, Versaci, F, Ten Berg, J, Casella, G, Wong, A S L, Kala, P, Diez Gil, J L, Carrillo, X, Dirksen, M T, Becerra-Muñoz, V M, Kang-Yin Lee, M, Juzar, D A, de Moura Joaquim, R, Paladino, R, Milicic, D, Davlouros, P, Bakraceski, N, Zilio, F, Donazzan, L, Kraaijeveld, A O, Galasso, G, Lux, A, Marinucci, L, Guiducci, V, Menichelli, M, Scoccia, A, Yamac, A, Ugur Mert, K, Flores Rios, X, Kovarnik, T, Kidawa, M, Moreu, J, Flavien, V, Fabris, E, Lozano Martìnez-Luengas, I, Boccalatte, M & ISACS-STEMI COVID-19 2022, ' COVID-19 pandemic, mechanical reperfusion and 30-day mortality in ST elevation myocardial infarction ', Heart, vol. 108, no. 6, pp. 458-466 . https://doi.org/10.1136/heartjnl-2021-319750, Heart, r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol, r-INCLIVA. Repositorio Institucional de Producción Científica de INCLIVA
- Accession number :
- edsair.doi.dedup.....f6e62531ea2ec90586da1fb8c7ea2452